Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-16T09:32:55.323Z Has data issue: false hasContentIssue false
  • English
  • Français

Select Recent Court Decisions

Published online by Cambridge University Press:  06 January 2021

Jonathan Amar  and
Adaline R. Strumolo
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case Report
Information
American Journal of Law & Medicine , Volume 33 , Issue 4 , December 2007 , pp. 703 - 708
Copyright
Copyright © American Society of Law, Medicine and Ethics and Boston University 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 489 F.3d 376 (D.C. Cir. 2007).

2 Id. at 376 – 77.

3 Id. at 378.

4 Id.

5 Id. at 379.

6 Id.

7 D.C. Code § 21 – 2210 (2001).

8 Does I Through III v. District of Columbia, 232 F.R.D. 18, 34 (D.D.C. 2005).Google Scholar

9 Id.

10 Tarlow, 489 F.3d at 376 – 77.

11 Id. at 381.

12 Id.

13 Id.

14 Id.

15 Id.

16 Id.

17 Id. at 382 – 83.

18 Id. at 382.

19 497 U.S. 261 (1990).

20 Tarlow, 489 F.3d at 383.

21 356 F.3d 348, 360 (2d Cir. 2004).

22 Tarlow, 489 F.3d at 383.

23 Id.

1 490 F. Supp. 2d 163 (D.N.H. 2007).

2 Id.

3 N.H. Rev. Stat. Ann. §§ 318:47-f, 318:47-g, 318-B:12(IV) (Supp. 2007).

4 The statute’s prohibition on the use of patient-identifiable data is not at issue in the case. IMS Health, 490 F. Supp. 2d at 170 n.6.

5 §§ 318:47-f, 318-B:12(IV).

6 IMS Health, 490 F. Supp. 2d at 174 n.9.

7 Id. at 174-175.

8 Id. at 175.

9 Id. (citing U.S. West, Inc. v. Fed. Commc’n Comm’n, 182 F.3d 1224, 1232 (10th Cir. 1999)).

10 Id. at 176.

11 Id.

12 Id. at 177 (quoting El Dia, Inc. v. P.R. Dep’t of Consumer Affairs, 413 F.3d 110, 113 (1st Cir. 2005)).

13 Id. at 178-179.

14 Id. at 179.

15 Id.

16 Id. at 180-181.

17 Id. at 180.

18 Id. at 180-181.

19 Id. at 181.

20 Id.

21 Id.

22 Id.

23 Id. at 182-183.

24 Wazana, Ashley, Physicians and the Pharmaceutical Industry, 283 JAMA 373, 373 (2000)CrossRefGoogle ScholarPubMed.

25 IMS Health, 490 F. Supp. 2d at 167.

26 See Wazana, supra note 24.

27 See, e.g., Haas, Jennifer S., Potential Savings from Substituting Generic Drugs for Brand-Name Drugs, 142 Annals Internal Med. 891 (2005)CrossRefGoogle ScholarPubMed.

28 Rachel Brand, Doc’s Data—A Privacy Question, State Legislatures, June 2007 at 46.

29 Id.